| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 78 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $721.86 | $794,046.00 | -4.7% | +14.7% | +27.4% | |
| Dec 28, 2022 | Coles N Anthony | Director | Sale+OE | 5,758 | $714.11 | $4,111,821.82 | -13.8% | +16.0% | +23.7% | |
| Dec 12, 2022 | McCourt Marion55 | EVP Commercial | Sell | 264 | $730.17 | $192,764.88 | -1.4% | +1.3% | +16.3% | |
| Dec 8, 2022 | Bassler Bonnie L59 | Director | Sale+OE | 218 | $779.00 | $169,822.00 | -16.8% | -2.6% | +9.8% | |
| Dec 2, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 610 | $756.66 | $461,563.68 | -0.7% | +0.3% | +6.3% | |
| Dec 1, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $758.17 | $75,817.49 | - | +1.2% | +7.0% | |
| Dec 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $756.19 | $831,809.00 | -5.3% | +1.2% | +7.0% | |
| Nov 23, 2022 | Van Plew Daniel P | EVP &General Mgr, Industrial | Sale+OE | 11,972 | $740.75 | $8,868,260.34 | -2.4% | +1.5% | +8.6% | |
| Nov 15, 2022 | Murphy Andrew J54 | EVP Research | Sale+OE | 3,720 | $727.81 | $2,707,467.33 | -0.3% | +4.8% | +8.7% | |
| Nov 8, 2022 | Brown Michael S49 | Director | Sale+OE | 4,495 | $754.44 | $3,391,191.11 | -11.8% | +3.8% | +9.4% |